Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (1251-1260 of 9,628) with videos related to

Pageof 963
Sort By:
Leukemia|February 25, 2006
hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemiaL J Campbell, C Fidler, H Eagleton, et al.
Leukemia|March 3, 2006
High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)E Jabbour, S Koscielny, C Sebban, et al.
Leukemia|February 8, 2008
Histone acetylation and DNA demethylation of B cells result in a Hodgkin-like phenotypeA Ehlers, E Oker, S Bentink, et al.
Leukemia|February 1, 1991
Limited combinatorial repertoire of gamma delta T-cell receptors expressed by T-cell acute lymphoblastic leukemiasT M Breit, I L Wolvers-Tettero, K Hählen, et al.
Leukemia|January 18, 2008
Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathwayW Zhang, M Konopleva, V R Ruvolo, et al.
Leukemia|April 4, 2008
A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosisA Quintás-Cardama, W Tong, H Kantarjian, et al.
Leukemia|April 4, 2008
Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanismH Zhang, D Trachootham, W Lu, et al.
Leukemia|March 14, 2008
The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursorsS Matarraz, A López, S Barrena, et al.
Leukemia|March 21, 2008
Rac GTPases as key regulators of p210-BCR-ABL-dependent leukemogenesisE K Thomas, J A Cancelas, Y Zheng, et al.
Leukemia|November 1, 1991
Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytesR Zambello, M A Cassatella, L Trentin, et al.
Pageof 963

Showing results (1251-1260 of 9,628) with videos related to

Sort By:
Pageof 963
Leukemia|February 25, 2006
hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemiaL J Campbell, C Fidler, H Eagleton, et al.
Leukemia|March 3, 2006
High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)E Jabbour, S Koscielny, C Sebban, et al.
Leukemia|February 8, 2008
Histone acetylation and DNA demethylation of B cells result in a Hodgkin-like phenotypeA Ehlers, E Oker, S Bentink, et al.
Leukemia|February 1, 1991
Limited combinatorial repertoire of gamma delta T-cell receptors expressed by T-cell acute lymphoblastic leukemiasT M Breit, I L Wolvers-Tettero, K Hählen, et al.
Leukemia|January 18, 2008
Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathwayW Zhang, M Konopleva, V R Ruvolo, et al.
Leukemia|April 4, 2008
A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosisA Quintás-Cardama, W Tong, H Kantarjian, et al.
Leukemia|April 4, 2008
Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanismH Zhang, D Trachootham, W Lu, et al.
Leukemia|March 14, 2008
The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursorsS Matarraz, A López, S Barrena, et al.
Leukemia|March 21, 2008
Rac GTPases as key regulators of p210-BCR-ABL-dependent leukemogenesisE K Thomas, J A Cancelas, Y Zheng, et al.
Leukemia|November 1, 1991
Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytesR Zambello, M A Cassatella, L Trentin, et al.
Pageof 963